approved

Приложение 4 от 02.12.2016 г.

Unique identificator:  29a722e1-1f02-41e7-bf3d-a1f8cb9b9c91

Description:

Приложение 4 от 02.12.2016 г.

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2016-12-05 15:13:07
  • Created by: georgi_sivchev
  • Updated at: 2018-10-16 08:26:43
  • Updated by: migrate_data
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 TWINRIX ADULT, Suspension for injection, 1ml, ml (1 dose = 1 ml), Pack: 1 pre-filled syringe + 1 separate needle GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 38.98 7.8 46.78 4% 1.56 40.54 8.11 48.65 16% 6.24 46.78 9.36 56.14 НСР-7782/28.12.2015 13.01.2016 13.01.2016 Активен 129
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 TWINRIX ADULT, Suspension for injection, 1ml, -, Pack: 1 pre-filled syringe + 1 separate needle GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 38.98 7.8 46.78 4% 1.56 40.54 8.11 48.65 16% 6.24 46.78 9.36 56.14 НСР-7782/28.12.2015 13.01.2016 13.01.2016 Неактивен 129
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 TWINRIX ADULT, Suspension for injection, 1ml, -, Pack: 1 pre-filled syringe + 1 separate needle GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 38.98 7.8 46.78 4% 1.56 40.54 8.11 48.65 16% 6.24 46.78 9.36 56.14 НСР-7782/28.12.2015 13.01.2016 13.01.2016 Неактивен 129
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) ЕU/1/96/020/001-009 TWINRIX ADULT, Suspension for injection, 20 mcg/1 ml, 1 dose=1 ml, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Belgium 40.33 8.07 48.4 4% 1.61 41.94 8.39 50.33 16% 6.45 48.39 9.68 58.07 цената се заличава КЦРР-1641/15.11.2012 КЦРР-743/07.06.2012 26.06.2012 26.06.2012 Заличен 1244
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) ЕU/1/96/020/001-009 TWINRIX ADULT, Suspension for injection, 20 mcg/1 ml, 1 dose=1 ml, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Belgium 42.36 8.47 50.83 6% 2.54 44.9 8.98 53.88 18% 7.62 52.52 10.5 63.02 КЦ-1483/31.03.2010 21.04.2010 21.04.2010 Неактивен 1244
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 Twinrix Adult suspension injection vial 20 mcg 1 ml, Hepatitis A virus (inactivated) 720 ELSA Units, Hepatitis B surface antigen 20 mcg x 1 dose, Suspension for injection, Hepatitis A virus (inactivated) 720 ELISA Units / Hepatitis B surface antigen 20 μg, 1 dose=1 ml, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 42.36 8.47 50.83 4% 1.69 44.05 8.81 52.86 16% 6.78 50.83 10.17 61 КЦ-262/27.10.2008 18.11.2008 18.11.2008 Неактивен 129
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80 mg/ 5, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 29.81 5.96 35.77 6% 1.79 31.6 6.32 37.92 18% 5.37 36.97 7.39 44.36 НСР-7909/28.01.2016.; НСР-10439/29.09.2016 02.11.2016 02.11.2016 Активен 3098
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80mg/ 5 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 31.63 6.33 37.96 4% 1.27 32.9 6.58 39.48 16% 5.06 37.96 7.59 45.55 НСР-7909/28.01.2016. 12.02.2016 12.02.2016 Неактивен 3098
Telmisartan, Amlodipine EU/1/10/648/023 TWYNSTA, Tablet, 80mg/ 10 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 31.2 6.24 37.44 4% 1.25 32.45 6.49 38.94 16% 4.99 37.44 7.49 44.93 НСР-8561/24.03.2016. 08.04.2016 08.04.2016 Активен 3330
Telmisartan, Amlodipine EU/1/10/648/023 TWYNSTA, Tablet, 80mg/ 10 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 33.27 6.65 39.92 4% 1.33 34.6 6.92 41.52 16% 5.32 39.92 7.98 47.9 НСР-6481/18.06.2015 04.07.2015 04.07.2015 Неактивен 3330
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80mg/ 5 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 33.17 6.63 39.8 4% 1.33 34.5 6.9 41.4 16% 5.31 39.81 7.96 47.77 НСР-6409/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3098
Telmisartan, Amlodipine EU/1/10/648/023 TWYNSTA, Tablet, 80mg/ 10 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 33.37 6.67 40.04 4% 1.33 34.7 6.94 41.64 16% 5.34 40.04 8.01 48.05 НСР-4939/22.10.2014 06.11.2014 06.11.2014 Неактивен 3330
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80mg/ 5 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 34.27 6.85 41.12 4% 1.37 35.64 7.13 42.77 16% 5.48 41.12 8.22 49.34 НСР-4338/05.08.2014 20.08.2014 20.08.2014 Неактивен 3098
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80mg/ 5 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 34.29 6.86 41.15 4% 1.37 35.66 7.13 42.79 16% 5.49 41.15 8.23 49.38 НСР-2123/14.12.2013 30.12.2013 30.12.2013 Неактивен 3098
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80mg/ 5 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 34.36 6.87 41.23 4% 1.37 35.73 7.15 42.88 16% 5.5 41.23 8.25 49.48 НСР-1948/06.12.2013 24.12.2013 24.12.2013 Неактивен 3098
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80mg/ 5 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 34.5 6.9 41.4 4% 1.38 35.88 7.18 43.06 16% 5.52 41.4 8.28 49.68 КЦРР-2603/14.03.2013 29.03.2013 29.03.2013 Неактивен 3098
Telmisartan, Amlodipine EU/1/10/648/023 TWYNSTA, Tablet, 80mg/ 10 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 34.21 6.84 41.05 4% 1.37 35.58 7.12 42.7 16% 5.47 41.05 8.21 49.26 КЦРР-2604/14.03.2013 29.03.2013 29.03.2013 Неактивен 3330
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80mg/ 5 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 45.67 9.13 54.8 4% 1.83 47.5 9.5 57 16% 7.31 54.81 10.96 65.77 КЦ-2444/07.07.2011 21.07.2011 21.07.2011 Неактивен 3098
Telmisartan, Amlodipine EU/1/10/648/023 TWYNSTA, Tablet, 80mg/ 10 mg, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 49.29 9.86 59.15 4% 1.97 51.26 10.25 61.51 16% 7.89 59.15 11.83 70.98 КЦ-2444/07.07.2011 21.07.2011 21.07.2011 Неактивен 3330
Tigecycline EU/1/06/336/001 Tygacil 10mg/ml-5ml, Powder for solution for infusion, 50, mg/5ml, Pack: 10 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 770.03 154.01 924.04 4% 10 780.03 156.01 936.04 16% 25 805.03 161.01 966.04 НСР-6856/30.07.2015 14.08.2015 14.08.2015 Активен 3316
Tigecycline EU/1/06/336/001 Tygacil 10mg/ml-5ml, Powder for solution for infusion, 50, mg/5ml, Pack: 10 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 770.03 154.01 924.04 4% 10 780.03 156.01 936.04 16% 25 805.03 161.01 966.04 НСР-6856/30.07.2015 14.08.2015 14.08.2015 Неактивен 3316
Tigecycline EU/1/06/336/001 Tygacil 10mg/ml-5ml, Powder for solution for infusion, 50, mg/5ml, Pack: 10 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 779.28 155.86 935.14 4% 10 789.28 157.86 947.14 16% 25 814.28 162.86 977.14 НСР-4877/17.10.2014 03.11.2014 03.11.2014 Неактивен 3316
Tigecycline EU/1/06/336/001 Tygacil 10mg/ml-5ml, Powder for solution for infusion, 50, mg/5ml, Pack: 10 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 788.65 157.73 946.38 4% 10 798.65 159.73 958.38 16% 25 823.65 164.73 988.38 НСР+2334/13.01.2014 28.01.2014 28.01.2014 Неактивен 3316
Tigecycline EU/1/06/336/001 Tygacil 10mg/ml-5ml, Powder for solution for infusion, 50, mg/5ml, Pack: 10 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 819.24 163.85 983.09 4% 10 829.24 165.85 995.09 16% 25 854.24 170.85 1025.09 промяна на обстоятелства решение КЦPP-1459/02.10.2012 КЦРР-975/16.07.2012 12.09.2012 12.09.2012 Неактивен 3316
Tigecycline EU/1/06/336/001 Tygacil 10mg/ml-5ml, Powder for solution for infusion, 50, mg/5ml, Pack: 10 Wyeth Europa Ltd., Обединено Кралство Wyeth Pharmaceuticals, Великобритания 892.74 178.55 1071.29 4% 10 902.74 180.55 1083.29 16% 25 927.74 185.55 1113.29 КЦ-397/07.01.2009 30.01.2009 30.01.2009 Неактивен 3316
Showing 9176 to 9201 of 10115 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте